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Abstract
Insulin-dependent diabetes mellitus is caused by autoimmune destruc-
tion of pancreatic ß cells. Non-obese diabetic (NOD) mice spontane-
ously develop diabetes similar to the human disease. Cytokines pro-
duced by islet-infiltrating mononuclear cells may be directly cytotoxic
and can be involved in islet destruction coordinated by CD4+ and
CD8+ cells. We utilized a semiquantitative RT-PCR assay to analyze
in vitro the mRNA expression of TNF- and IFN- cytokine genes in
isolated islets (N = 100) and spleen cells (5 x 105 cells) from female
NOD mice during the development of diabetes and from female CBA-j
mice as a related control strain that does not develop diabetes. Cy-
tokine mRNAs were measured at 2, 4, 8, 14 and 28 weeks of age from
the onset of insulitis to the development of overt diabetes. An increase
in IFN- expression in islets was observed for females aged 28 weeks
(149 ± 29 arbitrary units (AU), P<0.05, Student t-test) with advanced
destructive insulitis when compared with CBA-j mice, while TNF-
was expressed in both NOD and CBA-j female islets at the same level
at all ages studied. In contrast, TNF- in spleen was expressed at
higher levels in NOD females at 14 weeks (99 ± 8 AU, P<0.05) and 28
weeks (144 ± 17 AU, P<0.05) of age when compared to CBA-j mice.
The data suggest that IFN- and TNF- expression in pancreatic islets
of female NOD mice is associated with ß cell destruction and overt
diabetes.
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Introduction
Type I diabetes mellitus is a T cell-
dependent autoimmune disease resulting in
selective destruction of ß cells of the islet of
Langerhans (1). Non-obese diabetic (NOD)
mice spontaneously develop type I diabetes
mellitus and serve as an animal model for
human type I diabetes mellitus (2-4). The
occurrence of a mixed lymphocytic popula-
tion in pancreatic ß-islets (insulitis) can re-
sult in progressive ß cell destruction, insulin
deficiency and hyperglycemia. Cells such as
macrophages and dendritic cells appear early,
followed by CD4+ and CD8+ T cells (5-7).
The first stage of insulitis occurs when
the lymphocytic infiltrate is located around
the islet (peri-islet) without significant ß cell
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destruction and usually begins at 4 weeks of
age in both female and male NOD mice. The
second stage, that occurs between 12 and 25
weeks of age (median at 15 weeks of life), is
characterized by intra-islet infiltration and
an aggressive attack upon the insulin-
producing cells, leading to a loss of ß cell
mass and overt diabetes. Interestingly, in
most NOD mouse colonies (8) a clear sexual
dimorphism is present showing high inci-
dence of diabetes among females (60-90%)
and low incidence among males (10-20%).
Both CD4+ and CD8+ T cell subsets are
required for development of diabetes in NOD
mice (9-12). However, the precise mechan-
isms by which T cells destroy ß cells are
unclear. Studies on the correlation between
cytokines expressed in islets and autoim-
mune diabetes in NOD mice have demon-
strated that ß cell destructive insulitis is as-
sociated with increased levels of proinflam-
matory cytokines (IL-1, TNF- and IFN-)
(13-20). It has now been well documented in
vitro that certain cytokines are cytotoxic to
pancreatic islets. IL-1, TNF- and IFN-
impair insulin secretion and when they are
added to synergic cytokines their phlogistic
effect is amplified, leading to ß cell destruc-
tion in vitro (14,20), although in vivo the
direct cytotoxicity of cytokines to ß cells
remains to be demonstrated. On the other
hand, the cytokines can be cytotoxic to ß
cells by inducing nitric oxide and oxygen
free radicals (21-23).
Expression of cytokine mRNA in islet
lesion has been characterized by the reverse
transcriptase-polymerase chain reaction (RT-
PCR) assay. In NOD mice, the numbers of
infiltrating cells increase with age and there
is elevated expression of IL-2 and IFN-
after 13 weeks of age in NOD females (24).
Furthermore, there is evidence suggesting
that IFN- may be directly toxic to ß cells,
decreasing the secretion of insulin in vitro
(14,25). TNF- mRNA expression is de-
tected in islets of NOD mice; however, the
direct effect of TNF- on ß cells upon the
progression to diabetes remains unclear; it is
possible that TNF- can lead to insulitis but
not to diabetes (21,26). Nevertheless, taken
as a whole, the observations suggest that the
presence of these cytokines, IFN- and
TNF-, may be playing an important role in
ß cell destruction and development of diabe-
tes (27). However, the relation between the
expression of these cytokines in islets and in
spleen cells and the progression of autoim-
mune diabetes in NOD mice aged 2 to 28
weeks remains to be studied. The purpose of
the present study was to analyze the mRNA
expression of IFN- and TNF- in islets and
spleen of female NOD mice at five times (2,
4, 8, 14 and 28 weeks) from the onset of
insulitis to the development of overt diabe-
tes, using a semiquantitative RT-PCR assay.
Furthermore, we compared the degree of
insulitis severity detected by morphological
studies, and IFN-/TNF- expression at the
same time points.
Material and Methods
Animals and experimental groups
NOD/Uni mice originating from the
colony at INSERM U-25, Hospital Necker
(Paris, France) and maintained at the center
of animal breeding of the State University of
Campinas, São Paulo, Brazil (28) under germ-
free conditions were transferred to a specific
pathogen-free animal facility in our labora-
tory. The incidence of spontaneous diabetes
in our colony was 60% in females and 5% in
males by 25 weeks of age. The animals were
maintained on an autoclaved free water and
food regimen under 12-h cycles of darkness
and light. The animals used in this study
included female NOD and CBA-j mice as a
related strain that does not develop diabetes,
at 2, 4, 8, 14 and 28 weeks of age, and
diabetic NOD mice a few days after the onset
of the disease. Mice were monitored for the
onset of diabetes by measurements of urine
glucose using Test-strips (Eli Lilly do Brasil
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Ltda., São Paulo, SP, Brazil) twice a week.
The glucose concentration in blood obtained
from a tail vein was measured using Prestige
LX Smart System Test-strips (Home Diag-
nostic, Inc., Fort Lauderdale, FL, USA).
Consecutive readings of blood glucose lev-
els 300 mg/dl (12 mmol/l) accompanied by
glycosuria on two consecutive days were
considered to be diagnostic of diabetes on-
set.
In the first set of experiments, 42 female
NOD mice divided into six groups of 7 ani-
mals each at 2, 4, 8, 14 and 28 weeks of age,
10 diabetic mice (aged 17 to 28 weeks), and
25 CBA-j mice, as a non-correlated strain,
were divided into five groups of 5 animals
each at same age as NOD mice. The mice
were killed by a sodium pentobarbital over-
dose and the pancreas was removed for mor-
phological classification of islet inflamma-
tion stages (insulitis). In the second set of
experiments, 35 female NOD mice and 35
female CBA-j mice divided into five groups
of 7 animals each at 2, 4, 8, 14 and 28 weeks
of age were used. The pancreas was re-
moved at each time and islets were isolated
and separately processed. Total RNA was
extracted from a pool of 100 islets obtained
from 7 animals for semiquantitative study of
cytokine mRNA expression by RT-PCR.
Histological analysis
To evaluate the severity of insulitis in
non-diabetic females and diabetic female
NOD mice the pancreas from each animal
was snap-frozen in Tissue-Tek OTC embed-
ding compound (Miles Laboratories Inc.,
Clifton, NJ, USA) on liquid nitrogen. Cryo-
stat sections were prepared with a cryostat
model CM1850 (Leica Instruments, Nußluch,
Germany) as follows: nine consecutive
5-µm sections were cut and placed on differ-
ent slides coated with -methacryloxypropyl-
methoxysilane (Sigma, St. Louis, MO, USA)
with a cryostatic distance of 300 µm be-
tween sections. Eighteen slides with three
sections were obtained for each specimen.
The histological sections were stained with
hematoxylin and eosin and examined by light
microscopy (Zeiss, Axioscop, Jena, Ger-
many). The severity of insulitis was classi-
fied by the magnitude of mononuclear cell
infiltration: grade 0, intact islet, with no
infiltration by mononuclear cells; 1, peri-
and intra-islet infiltration of <25%; 2, intra-
islet infiltration of 25-80%; 3, invasive
insulitis of >80%; 4, destructive insulitis,
with total islet invasion by mononuclear cells.
A mean insulitis score was calculated. The
number of total islets was determined and
the mean was estimated considering the num-
ber of sections examined and animals studied.
Islet isolation
Pancreatic islets were isolated from mice
by stationary collagenase digestion of the
pancreas using previously described meth-
ods (29,30) with minor modifications. Mice
were anesthetized by intraperitoneal injec-
tion of 3% sodium pentobarbital (20 mg/kg).
The pancreas was excised, minced and di-
gested with collagenase V (Sigma) for 15
min. Islets were isolated and collected under
a dissection microscope with a micropipette.
The number of islets (50-100/mice) recov-
ered depended on age. After isolation, the
cell number was counted and viability was
checked by Trypan blue exclusion. Only a
batch of islets with more than 90% viability
was used for RT-PCR procedure.
Spleen cell isolation
Mice were anesthetized by intraperito-
neal injection of 3% sodium pentobarbital
(20 mg/kg). Spleen cells were excised, passed
through a stainless-steel mesh screen and
washed three times in Hank’s (Hyclone, CA,
USA) balanced salt solution. Isolated spleen
cells were diluted to 5 x 106 cells in a solu-
tion containing 4 M guanidinium thiocya-
nate, 0.1 M 2-ß-mercaptoethanol, 25 mM
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sodium citrate, pH 7.0, and 0.5% sarkosyl
(N-lauroylsarcosine, sodium salt; Sigma), fro-
zen in liquid nitrogen and maintained at
-80ºC until use.
Total RNA extraction
Total RNA was prepared by the guanidi-
nium thiocyanate method (31) from pooled
islets isolated from 7 female NOD mice (100
islets/mouse) and CBA-j mice (non-diabetic
animal control) at different ages (2, 4, 8, 14
and 28 weeks of age). Pooled islets were
immediately transferred to Rnase-free plas-
tic tubes containing 4 M guanidinium thio-
cyanate, 0.1 M 2-ß-mercaptoethanol, 25 mM
sodium citrate, pH 7.0, and 0.5% sarkosyl,
frozen in liquid nitrogen and maintained at
-80ºC until the time for use. All aliquots
were analyzed by spectrophotometry (Spec-
tra Max 190, Molecular Devices, Sunnyvale,
CA, USA) before use. The ratio of readings
at 260/280 nm was determined and only
samples presenting a ratio between 1.6 and
1.8 were used.
RT-PCR
cDNA was synthesized from 5 µg of total
RNA using 0.5 µl of Oligo d(pt) and ultrapure
water to complete 31 µl. Tubes were heated
to 65ºC for 10 min and then refrigerated at
4ºC for 5 min when 18 µl of reaction solution
(10 µl super RT buffer, 2 µl 0.5 mM dNTP
mix, 5 µl 0.1 M DTT and 1 µl RNAsin;
GibcoBRL, Life Technologies, Gaithersburg,
MD, USA) was added. The temperature was
then set at 42ºC for 2 min and 1 µl Super-
scriptTM RT (GibcoBRL) was added to each
tube. The reaction was developed at 42ºC for
50 min followed by 15 min at 70ºC and then
4ºC at the end. cDNA samples were stored at
-20ºC until the time for use.
PCR was performed in 200-µl tubes con-
taining 2 µl cDNA, 100 ng sense primer, 100
ng antisense primer, and 43 µl reaction solu-
tion (5 µl PCR buffer, 5 µl 0.5 mM dNTP
mix, 1.5 µl 50 mM MgCl2, and 31.5 µl
ultrapure water). Each sample was overlaid
with mineral oil (Sigma) and incubated in a
thermocycler (GeneAmpl 9700, Perkin-
Elmer, Foster City, CA, USA) using one
cycle at 94ºC for 3 min followed by 40
cycles of 94ºC for 60 s, 58ºC for 45 s and
72ºC for 90 s. PCR fragments were visual-
ized by agarose gel electrophoresis and ethi-
dium bromide staining. Sample contamina-
tion by genomic DNA was verified by sub-
mitting the RNA sample to PCR amplifica-
tion omitting the RT step. Cyclophilin (house-
keeping gene) was co-amplified as an inter-
nal control. The following primers were used:
TNF- (254 bp), sense 5'-CTTAGACTTTG
CGGAGTCCG-3', antisense 5'-CCCTGTCA
CTGGACCTGACA-3'; IFN- (428 bp),
sense 5'-CGCTACACACTGCATCTTGG,
antisense 3'-GGCTGGATTCCGGGCAA
CA; cyclophilin (276 bp), sense 5'-GACA
GCAGAAAACTTTCGTGC-3', antisense 5'-
GGTTCTGACTCACCGACCT-3'; insulin
(257 bp), sense 5'-GCTATAATCAGAGA
CATC-3', antisense 5'-GTTGCAGTAGTT
CTCCAGCTG-3'.
Semiquantitative analysis of RT-PCR products
PCR products were submitted to electro-
phoretic analysis in 1.5% agarose gel with
ethidium bromide (2/50 µl). Samples con-
tained 8 µl cDNA, 1.5 µl PCR loading buffer
and 5.5 µl ultrapure water and migrated in
the presence of TBE buffer containing 2 µl/
100 ml ethidium bromide for 45 min (70 V,
150 mA). PCR products were visualized
by excitation of ethidium bromide under
ultraviolet light and digitally recorded us-
ing the Nucleovision® system (Nucleo
Tech, San Mateo, CA, USA) and their
molecular weight and band pixel area were
calculated using the Gel Expert® Software
(NucleoTech).
Semiquantitative expression (SE) of ap-
optosis components was calculated for each
sample using the following formula and ex-
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pressed as arbitrary absorbance units (AU):
SE (AU) = pixel area of the product to be
analyzed/pixel area of cyclophilin x 100.
Statistical analysis
All results are reported as means ± SD.
Comparisons of semiquantitative measure-
ments of cytokine expression and score se-
verity were made using ANOVA or the un-
paired Student t-test.
Results
Insulitis kinetics in female NOD mice
Pancreatic islet infiltration by mono-
nuclear cells in female NOD mice was pro-
gressive from 4 to 28 weeks of age for both
diabetic and non-diabetic animals. These re-
sults are described below as mean ± SD
insulitis score and are summarized in Table 1.
At 8 weeks of life an increase of infiltra-
tive cells surrounding the islets (peri-islet,
grade 1, 39 ± 23, P<0.05) was observed and
the severity score increased at age 14, with
most islets being invaded by infiltrating cells
(grade 2, 44 ± 24, grade 3, 32 ± 15 and grade
4, 35 ± 15, P<0.01). The severity score at age
14 compared to 28 weeks showed grade 0,
39 ± 30 (P<0.05) and grade 1, 52 ± 9 (P<0.01).
The values for grades 2, 3 and 4 were not
statistically different (P<0.1).
In 28-week-old CBA-j animals and in
diabetic animals, insulitis scores between
grades 0 and 3 were the same for both groups.
Nevertheless, in 28-week-old animals the
grade 4 score (51 ± 23, P<0.02) was signifi-
cantly higher than in the diabetic group prob-
ably due to the smaller amount of islets than
in the non-diabetic animals.
Mean numbers of pancreatic islets per
animal did not differ significantly among
non-diabetic animals, in contrast to diabetic
animals whose total number of islets (96 ±
31, P<0.05) was significantly lower than in
the other animals.
Expression of IFN- and TNF- mRNA
In order to investigate the expression of
TNF- and IFN- mRNA in the autoimmune
diabetes process, multiple time point analy-
ses were performed to identify the associa-
tion between cytokine gene expression and
the infiltration of immune cells during dis-
ease development. All cDNA samples used
for the study expressed the product of the
housekeeping gene cyclophilin (276 bp) and
insulin (257 bp), confirming their quality
and the source. The expected products for
the genes of TNF- (254 bp) and IFN- (428
bp) were expressed in all animals studied.
Semiquantitative analysis of RT-PCR products
A cross-sectional study involving 7 fe-
male NOD mice at 2, 4, 8, 14 and 28 weeks
of age and CBA-j mice was performed. Two
cytokines, TNF- and IFN-, were exam-
Table 1. Insulitis scores as a function of age.
Week of life Grade
0 1 2 3 4
2 212 ± 42* 0 0 0 0
4 144 ± 35 17 ± 9* 0 0 0
4 144 ± 35 17 ± 9 0 0 0
8 142 ± 46 39 ± 23* 6 ± 5 5 ± 4 0
8 142 ± 46* 39 ± 23 6 ± 5 5 ± 4 0
14 39 ± 29 52 ± 9 44 ± 24* 32 ± 15* 35 ± 15*
14 39 ± 29* 52 ± 9* 44 ± 24 32 ± 15 35 ± 15
28 15 ± 15 19 ± 8 32 ± 13 31 ± 16 51 ± 23
28 15 ± 15 19 ± 8 32 ± 13 31 ± 16 51 ± 23*
Diabetic rats 5 ± 3 21 ± 11 22 ± 12 22 ± 11 27 ± 12
The pancreases were removed from 7 female NOD mice at the age of 2, 4, 8, 14 and
28 weeks. Three tissue sections from each diabetic animal were analyzed and pancre-
atic islet insulitis was graded from 0 to 4 according to severity. The analysis was
performed comparing ages 2-4, 4-8, 8-14, 14-28, and 28 weeks and diabetic rats. A
mean insulitis score was calculated and the total number of islets was estimated
considering the number of sections examined and the animals studied. Data concern-
ing grades of insulitis and severity of the islet inflammation process were assessed by
the unpaired Student t-test.
*P<0.05 for paired comparison among age groups. N = 55 female NOD mice.
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ined for these analyses. Total RNA samples
were prepared from the islets of NOD mice
at different ages, i.e., 2, 4, 8, 14 and 28
weeks, representing different stages of dis-
ease. From 2 to 14 weeks there was a nonsig-
nificant increase in IFN- mRNA expression,
which then increased significantly (149 ± 29
AU, P<0.05) in female NOD mice at 28 weeks
compared to both youngest groups of animals
and CBA-j mice at 14 and 28 weeks of life
(Figure 1A). However, in the spleen of these
animals the level of IFN- expression was not
significantly increased (P<0.1) (Figure 1B).
In contrast, the expression of TNF- in
islets of NOD and CBA-j mice progressively
increased from 2 weeks of age, being statis-
tically significant at 14 (99 ± 8 AU, P<0.05)
and 28 weeks of age (144 ± 17 AU, P<0.05)
and being related to the increase of infiltrat-
ing cells in pancreatic islets (Figure 2A). In
comparison with CBA-j mice, TNF- mRNA
levels in spleens from NOD females started
to increase significantly (168 ± 14 AU,
P<0.05) at 8 weeks of age (Figure 2B). Thus,
TNF- mRNA levels in islets and spleens
correlated with the inflammatory process
and diabetes risk in older NOD mice. In
contrast, islets of CBA-j animals expressed
low and constant levels at all ages studied.
Discussion
Several studies have correlated cytokine
expression by islets with the development of
autoimmune diabetes in NOD mice and have
demonstrated that islet destruction is associ-
ated with increased expression of cytokines
such as TNF- and IFN- (13-20). However,
the present study is the first to focus on
mRNA expression and the morphological
features of pancreatic islets in NOD mice
aged 2 to 28 weeks. Our results are consist-
ent with published data concerning the ex-
pression of TNF- and IFN- as a candidate
for the final effector of autoimmune diabetes
(20). The expression of a particular group of
Figure 2. Kinetics of TNF-
mRNA expression in islets (A)
and spleen (B) assessed by
semiquantitative RT-PCR in fe-
male NOD and CBA-j mice in a
time-course study (2, 4, 8, 14
and 28 weeks of age) represent-
ing different stages of the dis-
ease process. *P<0.05 com-
pared to CBA-j mice of the same
age (Student t-test). N = 55 fe-
male NOD and 25 female CBA-j
mice.
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Figure 1. Kinetics of IFN- mRNA
expression in islets (A) and
spleen (B) assessed by semi-
quantitative RT-PCR in female
NOD and CBA-j mice in a time-
course study (2, 4, 8, 14 and 28
weeks of age) representing dif-
ferent stages of the disease pro-
cess. *P<0.05 compared to
CBA-j mice of the same age (Stu-
dent t-test). N = 55 female NOD
and 25 female CBA-j mice.
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cytokines in islets can modulate the inflam-
matory process leading to ß cell destruction
or suppressing inflammation. In addition,
cytokines such as IL-1, TNF- or IFN-
impair insulin secretion and, when added in
combination, are destructive to islets (13,20).
In the present study, we examined the rela-
tions between TNF- and IFN- mRNA ex-
pression in pancreatic islets of NOD mice
and the progression of insulitis, its severity,
islet destruction and overt diabetes. Further-
more, the expression of these cytokine genes
was examined in spleen isolated at the same
time as the islets, as a central lymphoid
organ. IFN- is a product of the Th1 subset of
T lymphocytes, cells involved in cell-medi-
ated immune responses and related to modu-
lation of islet ß cell destruction (11,18,32).
Indeed, previous studies showed that diabe-
tes could be transferred to neonatal NOD
mice, suggesting that both CD4+ and CD8+
are required for the initiation of insulitis,
contributing to the development of diabetes
(9,33). Furthermore, the morphological find-
ings of the presence of macrophages in islet
infiltrating cells suggest their participation
in early events of the inflammatory reaction
which lead to the recruitment of T cells (5).
In the early stages of insulitis, at 2 and 4
weeks of age, the mild IFN- mRNA expres-
sion in islets and spleen coincides with the
low number of activated T cells in pancreatic
islets (24,26,34). However, with the increase
of infiltrating T cells in islets the level of
IFN- expression increases in older mice
after 14 weeks of age, associated with de-
structive insulitis (21,24,32). The cytotoxic
action of IFN- against islet ß cells has been
described in in vitro experiments (13,20). In
transgenic mice, the expression of IFN- in ß
cells can lead to insulitis and diabetes (35-
37). Thus, our results concur with studies
showing that IFN- mRNA expression cor-
relates with islet destructive insulitis and
diabetes development in NOD mice and
emphasizes the importance of IFN- in the
pathogenesis of autoimmune diabetes. How-
ever, in the present study, the group of fe-
male NOD mice studied at 14 weeks of age
(pre-diabetic stages) showed a decreased
expression of IFN- despite the presence of
advanced insulitis (grades 3 and 4). In con-
trast, the genetic absence of IFN- did not
prevent diabetes in NOD mice, but delayed
the onset of diabetes (38). Moreover, a pre-
vious study dissociated class I major histo-
compatibility complex upward regulation
from progression to diabetes due to local
IFN- action, suggesting that ß cells are not
the direct targets of IFN- in autoimmune
diabetes (37). This apparent contradiction
suggests that the levels of IFN- expression
at this age could determine, together with
other factors, the rate of development of
overt diabetes. On the other hand, the ex-
pression of IFN- mRNA levels in spleen did
not show a correlation with severity of
insulitis progression, suggesting a compart-
mental IFN- response.
The levels of TNF- gene expression
progressively increased with age, with over-
expression being observed at the 28th week.
In some cases, TNF- expression did not
correlate with the progression of diabetes,
suggesting that TNF- can be more impor-
tant for the development and maintenance of
insulitis than diabetes (39,40).
On the other hand, TNF- was present in
spleen at all ages and was overexpressed at
14 weeks of life. Analysis of TNF- expres-
sion in NOD mice showed higher levels of
mRNA in spleen than in pancreatic islets,
probably due to the high number of mono-
nuclear cells present in the spleen. In addi-
tion, comparative analysis of TNF- expres-
sion in spleen showed higher levels in islets
and spleen of NOD mice than CBA-j mice.
Finally, in the present study we show the
association between IFN- and TNF- expres-
sion and insulitis severity and its age-depend-
ent property. Taken together with other re-
ports, our results emphasize the relevance of
the participation and possible synergism of
IFN-/TNF- in the pathophysiology of
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